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1. Introduction 
One of the peculiarities of  the mitochondrial ADP/ 
ATP carrier is its ability to bind, in an asymmetric 
manner, two specific natural inhibitors, ATR and BA, 
and their derivatives, CATR, Ac-CATR and IsoBA; 
the atractylosides bind to the ADP/ATP carrier from 
the outside of mitochondria, nd the bongkrekic acids 
from the inside [1 ]. Immunological [2] and fluores- 
cence [3] studies have provided evidence that the 
conformation assumed by the ADP/ATP carrier pro- 
tein is different, depending upon whether the carrier 
binds the atractylosides (ATR conformation) or the 
bongkrekic acids (BA conformation). A minimal 
hypothesis formulated by our group [4,5] to explain 
the binding asymmetry of the ADP/ATP carrier pro- 
tein with respect o the atractylosides and bongkrekic 
acids was that each family of inhibitors is recognized 
by a specific pre-existing sequence of amino acids 
belonging to the ATR and BA sites, although overlap- 
ping of the ATR and BA sites was not excluded. The 
fact that ATR and BA compete for binding was inter- 
preted by indirect interaction between ATR and BA 
sites mediated by conformational changes. On the 
basis of  current views on transport mechanism [6], 
the ADP/ATP carrier may be described as a dimer 
limiting a channel opened alternatively to the outside 
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Fig.1. The double inhibitor site model: This model assumes 
2 pre-existing specific binding sites for ATR and BA. The 
ADP/ATP site is capable of reorientation, i.e., it can be 
exposed to the outside and inside alternatively, and takes 
accordingly the outer and inner conformation. The outer 
conformation equivalent to the ATR conformation is stabi- 
lized by ATR or its derivatives. The inner conformation equiv- 
alent o the BA conformation is stabilized by BA or its deriv- 
atives. Note that the ATR, BA and ADPJATP sites can overlap. 
and the inside (outer and inner conformations), and 
through which the substrate is directed to either side 
[4]. As a consequence, inhibition of ADP/ATP trans- 
port by ATR and BA would be related to the immo- 
bilization of the carrier in the outer and inner confor- 
mations, respectively (fig.l). In the original version of 
his one-site mechanism, Klingenberg [7] postulated 
that all specific ligands (substrates and inhibitors) of 
the ADP/ATP carrier bind to a common area. Compe- 
tition between ATR and BA for binding was explained 
to be the result of mutual exclusion for access to the 
same site. In the course of ADP/ATP transport, he 
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carrier site was supposed to adopt two different con- 
formational states, the c-state and the m-state, corre- 
sponding to whether the site is turned to the outside 
or to the inside respectively (which is the equivalent 
of the outer and inner conformations in the preceding 
formulation). The c-state would be recognized specif- 
ically by ATR, and the m-state by BA. In [8] it was 
admitted that beside the connnon binding area, called 
also binding center, molecules of ATR and BA should 
occupy additional areas, although no specific function 
was ascribed for these additional areas. In brief, 
Klingenberg et al. [7,8] and our group [4,5] agree on 
the two different extreme conformations a sumed by 
the ADP/ATP carrier protein (ATR conformation or 
c-state, and BA conformation orm-state). The identity 
of the ATR and BA sites remains, however, a matter 
of debate (two pre-existing sites capable of interacting 
and changing their conformation [4,5] or same site 
with two possible conformations [7,8]). 
Because the ADP/ATP carrier is unique among 
transport systems by its ability to be probed in two 
conformations (ATR and BA conformations) that 
probably correspond to two frozen states of the trans- 
port process, full elucidation of the topology of the 
ATR and BA sites is clearly desirable for better under- 
standing of the functioning of this carrier. Along this 
line, selective chemical modifications of strategic 
amino acids in the ADP/ATP carrier have already pro- 
vided interesting data [4,5,8]. The penetrant reagents 
used so tar and their main targets include NEM (SH 
groups) [91, HNB (tryptophanyl residues) [10], 
phenylglyoxal nd butanedione (arginyl residues [11, 
12]). Inactivation of the binding properties of the 
ADP/ATP carrier by UV light was possibly due to 
modification of tryptophanyl residues [4]. NEM, 
HNB and UV light were found to alter primarily ATR 
binding. Phenylglyoxal nd butanedione altered both 
ATR and BA binding, although ATR binding was 
inhibited 3-4-times more than BA binding. Tile 
potentiating or protective ffects of a number of 
parameters on inactivation by the above reagents, 
reported in [5], were consistent with the dual-inhib- 
itor site mechanism [4]. However, in [8] it was claimed 
that all the above modifications stabilized the m-state, 
thus preventing ATR binding, and they maintained 
that the single site model could accommodate all our 
results. 
These experiments show that the single-site model 
[8] cannot explain all inactivation data; for example, 
stabilization of the m-state by preincubation of mito- 
chondria with isoBA did not enhance inactivation of 
Ac-CATR binding by butanedione. The same observa- 
tion holds for another eagent, EEDQ, highly specific 
for the activation and modification of carboxyl groups 
[I3,14]. Further, tile protection afforded by ADP on 
butanedione inactivation of both Ac-CATR and BA 
binding could not fit the one-site model. The data are 
better explained by the dual inhibitor-site model, 
with possible partial overlapping of the sites, as pro- 
posed in [4,5]. 
2. Materials and methods 
2.1. Materials 
[3H]Atractyloside and [3Hlbongkrekic acid were 
prepared as in [ 15 ] and [ 16], respectively. Isobong- 
krekic acid was prepared as in [17], and [14C]acetyl- 
carboxyatractytoside as in [18], except hat the puri- 
fication procedure by TLC chromatography and 
DEAE-cellulose was replaced by a reverse-phase high- 
pressure liquid chromatography on a Waters apparat us 
equipped with a C ls-microbondapack colmnn, with 
the mobile phase made of water, methanol, acetic 
acid and 1 M ammonium acetate (60/40/1/2, by vol.). 
Atractyloside was purchased from Sigma and ADP 
from PL Biochemicals. 
2.2. Subcellular preparations 
Rat heart mitochondria were isolated as in [ t9]. 
2.3. Chemical modifications 
In the case of NEM modification, freshly" prepared 
rat heart mitochondria were suspended at 1 mg/ml in 
saline buffer made of 120 mM KC1, 10 mM MOPS, 
1 mM EDTA (pH 7.2) supplemented with 10/~M 
ADP. After 5 rain preincubation at25°C under aero- 
biosis, NEM was added to final conc. 200 #M. After 
different periods of reaction with NEM at 25°C, ali- 
quot fractions were withdrawn and diluted 5-fold 
with 4 ml ice-cold standard medium made of 120 mM 
KC1,10 mM MES, 1 mM EDTA (pH 6.5) supplemented 
with 1 mM cysteine to stop the NEM reaction. [14C]- 
Ac-CATR binding was assayed by addition of a satu- 
rating concentration of [ t4C] Ac-CATR (2 nmol/rng 
protein) and 10/~M ADP. 
Treatment of mitochondria with EEDQ was carried 
out at 25°C in the above standard medium (pH 6.5) 
using 1 mg mitocliondrial protein/ml. At zero time, 
EEDQ was added upon vigorous tirring. The reaction 
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was stopped by a 5-fold dilution with the ice-cold 
standard medium, and 2 nmol [ 14C]  Ac-CATR/mg 
protein and 10 #M ADP were added for study of 
[14C]Ac4~ATR binding. 
Butanedione inactivation was performed according 
to [20], in a medium made of 70 mM borate and 
50 mM KC1 (pH 8) at 25°C. Mitochondrial protein 
was 1 mg/ml. Butanedione was 5 mM for ATR binding 
inactivation, or 10 mM for BA binding inactivation. 
The reaction was stopped by cooling to 0°C and 
lowering the pH to 6.5 by a 5-fold dilution with 4 ml 
50 mM KC1,70 mM MES (pH 6.4). This latter medium 
was supplemented with 10/aM ADP and a saturating 
concentration of [14C]Ac-CATR or [3H]BA (2 nmol/ 
mg protein) for binding assays. 
The assays for [14C]Ac-CATR or [3H]BA binding 
were performed by incubation of the chemically 
modified mitochondria for 30 min at 0°C with the 
radioactive ligand, followed by centrifugation for 
5 rain at 22 000 × g. The pellets were digested with 
1 ml 5% Triton X-100 and 05 M NaC1, and the radio- 
activity was counted by liquid scintillation. Binding 
controls, without chemical modifiers, were run to 
take into account he small spontaneous decrease in 
[14C]Ac-CATR binding capacity, due to incubation 
of mitochondria at 25°C. In some experiments, 
unlabelled ATR or isoBA were added prior to the 
modification step. As noticed above, a small amount 
of ADP (10/iM final conc.) was systematically added 
with [~4C]Ac-CATR or [3H]BA. At this low concen- 
tration ADP did not perturb Ac-CATR binding [ 18]; it 
even slightly enhanced BA binding [ 16]; furthermore, 
ADP allowed the efficient removal of bound isoBA 
by Ac4SATR and that of bound ATR by BA. 
3. Results 
3.1. Effect o f preincubation of mitochondria with 
isoBA on inhibition of Ac-CA TR binding by 
NEM, butanedione and EEDQ 
NEM inhibits ATR binding [21] but not BA bind- 
ing [16], and butanedione inhibits ATR binding 3-4- 
times faster than BA binding [5]. Like NEM, EEDQ 
inhibits ATR binding without modification of BA 
binding (fig.2). In all cases, the inhibition of ATR 
(and BA) binding caused by covalent binding of NEM 
[21], butanedione [5] and EEDQ (fig.2) is an all-or- 
none process, i.e., that the binding capacity of mito- 
chondria for ATR (or BA) is decreased, whereas the 
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Fig.2. Effect of EEDQ on ATR and BA binding to heart 
mitochondria: The incubation conditions are in section 2. 
Mitochondria were treated by 2 mM EEDQ for 25 min at 25°C. 
affinity of the remaining sites for ATR or BA remains 
unaltered. This is typical of an inactivation process. 
Inhibition of ATR binding by NEM requires prein- 
cubation of the mitochondria with traces of ADP or 
ATP [21]. This result was explained in [8] by an 
ADP-induced shift from the c-state (with high affinity 
for ATR) to the m-state (which is unable to bind 
ATR); it was further postulated [8] that SH-groups 
buried in the c-state are unmasked in the m-state, and 
can therefore be alkylated by NEM, resulting in a 
100~ ~ isoBA ~. 
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Fig.3. Effect of  preincubation of heart mitochondria with 
isoBA on the inhibition of  [ z4CJAc-CATR binding by NEM, 
butanedione and EEDQ. Unlabelled isoBA was added prior to 
the chemical modification, at 2 nmol /mg protein final conc. 
The incubation conditions are given in section 2. The t ime 
scale in abscissa corresponds to the incubation period with 
200 ~M NEM, 5 mM butanedione or 2 mM EEDQ. The 
amounts o f  bound [14C]Ac-CATR in the absence of  chemical 
modifiers (100% binding) were 0.95 and 1.15 nmol]mg pro- 
tein depending on whether the mitochondria are preincubated 
with or without isoBA. 
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Fig.4. Sensitization of [ 3H]BA binding to butanedione inhi- 
bition by preincubation with ATR. Heart mitochondria were 
suspended inborate buffer (pH 8.0) (cf. section 2). A frac- 
tion of the suspension was supplemented with unlabelled 
ATR 2 nmol/mg protein. At time zero, 10 mM butanedione 
was added, and at the times indicated on the abscissa, 1 ml 
aliquot of the suspension was withdrawn and diluted as in 
section 2for assay of [ 3H ] BA binding. The amounts of bound 
[3H]BA in the absence of chemical modifiers (100% binding) 
were 0.85 and 1.00 nmol/mg protein, with mitochondria 
preincubated with or without ATR, respectively. 
frozen m-state favorable to the binding of BA, but 
not to that of ATR. The reasoning in [8] was extended 
to all the reagents examined so far, which in fact have 
been found to inhibit ATR binding more than BA 
binding (cf. section 1). If the above reasoning isvalid, 
it follows that a shift from the c-state to the m-state, 
induced by addition of isoBA, might potentiate, like 
ADP does, the inhibitory effect of NEM, EEDQ and 
butanedione on ATR binding. In the experiment illus- 
trated in fig.3, ATR was substituted for by the tighter 
ligand, Ac-CATR, and BA by the looser ligand, isoBA. 
These conditions facilitated the displacement of isoBA 
bound during the preincubation period by the further 
added [~4C]Ac-CATR. As shown in fig.3, in contrast 
with the prediction in [8], opposite ffects of prein- 
cubation with isoBA on NEM and butanedione inhibi- 
tion were obtained, lsoBA increased inhibition of 
[~4C]Ac-CATR binding brought about by NEM, and 
it protected [14C]Ac-CATR binding against butane- 
dione inhibition. It had no effect on inhibition of 
[14C]Ac-CATR binding by EEDQ. In the case of 
butanedione, which inactivates both BA and ATR 
binding, the reverse xperiment was carried out ,which 
consisted in testing the binding of [3H]BA to mito- 
chondria fter pretreatment by ATR and then inhibi- 
tion by butanedione. The results howed that ATR 
preincubation potentiated inhibition of BA binding 
by butanedione (rigA). 
3.2. Effect of ADP on inhibition of/14C]Ac-CATR 
and [ 3H]BA binding by bu tanedione 
A crucial point of the one-site mechanism is that, 
in the absence of external ADP, the ADP/ATP carrier 
site is turned to the outside (c-state) [8], and that a 
trace of external ADP induces the site-shift from the 
100 
8o 
~: 70 
Y 6o 
u 
a 
z z,0 
o 113 
30 
1" I I I I I 
0 5 10 15 20 25 
INCUBATION TIME (min) 
Fig.5. ADP-induced stimulation of NEM inhibition of [ ~4C]- 
Ac-CATR binding. Heart mitochondria were suspended inthe 
MOPS buffer, with or without 10 #M ADP (cf. section 2). At 
zero time, 200 ~zM NEM was added. The assay was continued 
as in section 2. The values of bound [~4C]Ac-CATR corre- 
sponding to 100% binding is 1.10 nmol/mg protein. 
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Fig.6. Effects of preincubation with ADP on butanedione 
inhibition of [ J4C]Ac-CATR and [ 3H]BA binding. Heart 
mitochondria were suspended in the presence or absence of 
1 mM ADP in a borate medium (pH 8.0). The further steps 
(reaction with b utanedione), followed by binding of [ ~ 4C] Ac- 
CATR or [3H]BA were done as in section 2. The values of 
bound ['*C]Ac-CATR and [3H]BA corresponding to 100% 
binding are 1.10 and 0.98 nmol/mg protein, respectively. 
216 
Volume 131, number 2 FEBS LETTERS August 1981 
c- to the m-state. This postulated effect of ADP was 
supported by the finding that/~M levels of externally 
added ADP enhanced the NEM inhibition of [3H] ATR 
binding [21 ] and [14C] Ac-CATR binding (fig.5). Just 
the opposite was found when butanedione was used 
as inactivating reagent instead of NEM. Micromolar 
levels of ADP had no enhancing effect of the kinetics 
of inhibition. Further, when added at mM levels, ADP 
protected both [14C]Ac-CATR binding and [3H]BA 
binding against butanedione inhibition (fig.6). It is 
therefore clear that the effect exerted by ADP on the 
inhibition of ATR or BA binding by chemical modifiers 
is more complex than claimed by [8]. It must be added 
that the protective ffect of ADP against butanedione 
inhibition was shared also by ATP, but not by other 
nucleotides, which points to the specificity of the 
effect. 
4. Discussion 
A number of penetrant reagents have been used to 
study the response of ATR and BA binding to chem- 
ical modifications on specific amino acid residues of 
the ADP/ATP carrier [4,5,8,21 ]. In [8] chemical 
reagents like NEM, phenylglyoxal, butanedione and 
others, that inhibit more ATR binding than BA bind- 
ing, were proposed to stabilize the ADP/ATP carrier 
in the m-state (cf. section 1); it follows that, once the 
carrier conformation is frozen in the m-state corre- 
sponding to the BA or inner conformation, it can still 
bind BA, but can no longer bind ATR. To test the 
above predictable ffects of chemical reagents, we 
conducted a series of experiments in which the m-state 
(or inner conformation) was induced by addition of 
isoBA or ADP, and the c-state (or outer conformation) 
by addition of ATR. The data obtained for NEM inhi- 
bition were consistent with the idea that NEM reacts 
with SH group(s) at distance from the ATR (or BA) 
site, resulting in the stabilization of the m-state (or 
BA conformation). However, the data on EEDQ and 
butanedione inhibition clearly showed that the chem- 
ical impact of these reagents could not be interpreted 
as simply as for NEM. For example, contrary to 
expectation, addition of isoBA prior to modification 
of mitochondria by EEDQ did not increase EEDQ 
inhibition of Ac-CATR binding. Whereas NEM and 
EEDQ inhibit Ac-CATR binding, but not BA binding, 
arginine reagents like phenylglyoxal nd butanedione 
were found to inhibit not only ATR binding, but also 
BA binding, a crucial fact which was overlooked in 
[8]. IsoBA preincubated with mitochondria protected 
inhibition of [ 14C] Ac-CATR binding by butanedione. 
However, preincubation with ATR led to enhance- 
ment of the inhibition of BA binding by butanedione. 
The ATR conformation seems therefore more reactive 
than the BA conformation to butanedione; yet ATR 
protected its own binding site against butanedione. 
Although a first view, these data are difficult to rec- 
oncile, they can be rationalized on the following basis: 
1. Butanedione would modify arginyl residue(s) at 
the ATR site; this is consistent with the rapid inhi- 
bition of ATR binding; 
2. Butanedione would act on other arginine residue(s) 
at distance from the ATR and BA sites, resulting 
in the shift and stabilization of the carrier protein 
in the ATR conformation or c-state; this would 
explain the slow loss of BA binding. 
The postulated rapid inhibition of ATR binding by 
butanedione modification of arginyl residue(s) at the 
ATR site is in accordance with the linear relationship 
previously found between the inhibition of ATR 
binding by phenylglyoxal nd the binding of [14C]- 
phenylglyoxal to arginyl residue(s) in the carrier pro- 
tein [5], which suggests a direct titration of the ATR 
site. 
Considering now the effects of ADP (or ATP) on 
inhibition of Ac-CATR and BA binding by NEM and 
butanedione, it is obvious that NEM and butanedione 
inhibitions respond to ADP in different ways and 
therefore involve different mechanisms: 
(i) ADP exerts a protective ffect against butane- 
dione inhibition; on the contrary, ADP enhances 
NEM inhibition; 
(ii) Butanedione inhibition is prevented by mM levels 
of ADP; enhancement of NEM inhibition requires 
only #M levels of ADP. 
Whereas the enhancing effect of ADP on NEM inhibi- 
tion of Ac-CATR binding (fig.5) may be interpreted 
by a shift of the substrate site from the e-state to the 
m-state [8], this interpretation is no longer tenable to 
explain the protection afforded by mM levels of ADP 
against butanedione inhibition of Ac-CATR binding 
and BA binding. A possible xplanation of these data 
is that the substrate site of the carrier (to which ADP 
or ATP specifically binds) partially overlaps the BA 
and ATR sites. It is noteworthy that our inactivation 
data are not incompatible with a sequential mechanism 
of ADP/ATP transport involving a ternary complex 
consisting of the carrier and two nucleotides, one 
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coming from the inside, the other from the outside 
[22,23]; this would lead to assume that each subunit 
of  the dimer in the model  of  fig.1 contains a nucleo- 
tide binding site. 
These data are consistent with the idea that the 
binding sites for ATR and BA differ by at least a few 
amino acid residues [5]; it remains quite possible that 
the ATR and BA sites share a common area which 
overlaps the ADP/ATP site. It must be stressed that 
the dual inhibitor site model does not preclude alter- 
nating reorientation o f  the substrate site, nor the con- 
formational changes associated with the reorientation. 
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